Heart rate variability, as determined from 24-hour Holter recordings, represents a noninvasive parameter for studying the autonomic control of the heart. It decreases with certain disease states characterized by autonomic dysfunction such as congestive heart failure. No study in healthy or cardiac children has been performed to determine the correlations between and within time and frequency domain indices of heart rate variability. We examined five time domain (SDNN, SDNNi, SDANNi, rMSSD and pNN50) and five frequency domain measures (ULF, VLF, LF, HF and balance LF/HF) in 200 healthy children and 200 children with congenital heart disease, aged 3 days to 14 years. All measures were significantly correlated with each other. However, the strength of correlation varied greatly. Our data show that variables strongly dependent on vagal tone (rMSSD, pNN50 and HF) were highly correlated (r value > 0.90), as well as SDNN and SDANNi. We conclude that certain time and frequency domain indices correlate so strongly with each other that they can act as surrogates for each other.

1.
Finley JP, Nugent ST: Heart rate variability in infants, children, and young adults. J Autonom Nerv Syst 1995;51:103–108.
2.
Goto M, Nagashima M, Baba R, Nagano Y, Yokota M, Nishibata K, Tsuji A: Analysis of heart rate variability demonstrates effects of development on vagal modulation of heart rate in healthy children. J Pediatr 1997;130:725–729.
3.
Massin M, von Bernuth G: Normal ranges of heart rate variability during infancy and childhood. Pediatr Cardiol 1997;18:297–302.
4.
Finley JP, Nugent ST, Hellenbrand W, Craig M, Gillis DA: Sinus arrhythmia in children with atrial septal defect: An analysis of heart rate variability before and after surgical repair. Br Heart J 1989;61:280–284.
5.
Gordon D, Herrera VL, McAlpine L, Cohen RJ, Akselrod S, Lang P, Norwood WI: Heart rate spectral analysis: A noninvasive probe of cardiovascular regulation in critically ill children with heart disease. Pediatr Cardiol 1988;9:69–77.
6.
Massin M, Derkenne B, von Bernuth G: Heart rate behavior in children with atrial septal defect. Cardiology 1998;90:269–273.
7.
Massin M, von Bernuth G: Clinical and hemodynamic correlates of heart rate variability in children with congenital heart disease. Eur J Pediatr 1998;157:967–971.
8.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability; standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043–1065.
9.
Saul JP, Kaplan DT, Kitney RI: Non-linear interactions between respiration and heart rate. A phenomenon common to multiple physiologic states; in Proceedings comp in Cardiology 15. Los Alamitos, IEEE Computer Society, 1988, pp 299–302.
10.
Saul JP, Berger RD, Chen MH, Cohen RJ: Transfer function analysis of autonomic regulation. II: Respiratory sinus arrhythmia. Am J Physiol 1989;256:H153–H161.
11.
Kleiger RE, Bigger JT, Bosner MS, Chung MK, Cook JR, Rolnitzky LM, Steinman R, Fleiss HL: Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol 1991;68:626–630.
12.
Bigger JT, Albrecht P, Steinman RC, Rolnitzky LM, Fleiss JL, Cohen RJ: Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction. Am J Cardiol 1989;64:536–538.
13.
Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN: Correlations among time frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992;69:891–898.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.